Stockscreener 앱 받기
3.48
0.29%
-0.01
전일 마감가:
$3.49
열려 있는:
$3.5
하루 거래량:
476.90K
Relative Volume:
0.31
시가총액:
$91.40M
수익:
-
순이익/손실:
$-40.19M
주가수익비율:
-1.4844
EPS:
-2.3444
순현금흐름:
$-38.49M
1주 성능:
+8.07%
1개월 성능:
-75.66%
6개월 성능:
-56.82%
1년 성능:
-57.92%
1일 변동 폭
$3.27
$3.56
1주일 범위
$2.77
$3.67
52주 변동 폭
$2.66
$16.00
Elicio Therapeutics Inc Stock (ELTX) Company Profile
명칭
Elicio Therapeutics Inc
전화
(857) 209-0050
주소
451 D STREET, 5TH FLOOR, BOSTON
Compare ELTX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
3.48 | 91.40M | 0 | -40.19M | -38.49M | -2.3444 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Elicio Therapeutics Inc Stock (ELTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Ladenburg Thalmann | Buy |
| 2026-03-10 | 개시 | Rodman & Renshaw | Buy |
Elicio Therapeutics Inc 주식(ELTX)의 최신 뉴스
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therapeutics, Inc. (ELTX) And Encourages Shareholders to Connect - ACCESS Newswire
Enterprise value to revenue forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elicio Therapeutics, Inc. (ELTX) And Encourages Shareholders to Reach Out - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc.ELTX - PR Newswire
Why Is ELTX Stock Falling Today? - Stocktwits
[SCHEDULE 13G/A] Elicio Therapeutics, Inc. Amended Passive Investment Disclosure - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
2026-07-08 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Shareholders to Learn More About the Investigation | NDAQ:ELTX | Press Release - Stockhouse
ELICIO THERAPEUTICS ANNOUNCES CLOSING OF $15 MILLION REGISTERED DIRECT OFFERING - Moomoo
Elicio Therapeutics closes $15 million stock offering - Investing.com
Elicio Therapeutics Closes $15 Million Registered Direct Offering - marketscreener.com
Elicio Therapeutics closes $15 million stock offering By Investing.com - Investing.com South Africa
Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering - The Manila Times
Elicio closes $15M stock sale to fund KRAS cancer trial work - Stock Titan
Elicio Therapeutics, Inc. (ELTX) Investigation: Bronstein, Gewirt - The National Law Review
Enterprise value to EBIT forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Elicio Therapeutics (ELTX) Stock Forum and Discussion - Moomoo
Price to sales forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Enterprise value to EBITDA forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Elicio Therapeutics, Inc. (ELTX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Elicio Therapeutics stock tumbles on $15M offering - Investing.com
Elicio Therapeutics stock tumbles on $15M offering By Investing.com - Investing.com India
Form 424B5 Elicio Therapeutics Inc For: 2 July By Investing.com - Investing.com India
Form 424B5 Elicio Therapeutics, - StreetInsider
Elicio Therapeutics (ELTX) raises ~$15.0M via 4.38M-share placement - Stock Titan
Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial Disappointment - Yahoo Finance
Elicio Therapeutics raises $15M in registered direct offering By Investing.com - Investing.com Australia
Elicio Therapeutics Prices $15 Million Registered Direct Offering at $3.43; Signs Purchase, Placement Pacts - TradingView
Elicio Therapeutics (ELTX) prices $15M registered direct equity offering - Stock Titan
Elicio Therapeutics Prices $15 Million Direct Offering - marketscreener.com
Elicio locks in $15M to fund Phase 1 KRAS cancer trial - Stock Titan
Elicio Therapeutics prices $15M stock offering to fund cancer immunotherapy trials. - Pluang
Elicio Therapeutics raises $15M in registered direct offering - Investing.com
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering - The Manila Times
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering - GlobeNewswire Inc.
Price to book forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therapeutics, Inc. (ELTX) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therap - The National Law Review
Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 2000 Index - marketscreener.com
Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 2500 Growth Benchmark - marketscreener.com
Elicio Therapeutics, Inc.(NasdaqCM:ELTX) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Elicio Therapeutics, Inc. (ELTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Elicio Therapeutics Joins Russell 2000 and 3000 Indexes (ELTX) - GuruFocus
Elicio Therapeutics added to Russell 2000 and 3000 indexes - Investing.com
Elicio Therapeutics added to Russell 2000 and 3000 indexes By Investing.com - Investing.com South Africa
Elicio Therapeutics, Inc.(NasdaqCM:ELTX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes - The Manila Times
Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 2000 Growth Benchmark - marketscreener.com
Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 3000E Growth Benchmark - marketscreener.com
Elicio Therapeutics Inc (ELTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):